Osteopontin (OPN) has previously been identified as a target of HH/GLI signaling in melanoma cells.31 In the present study, however, we did not detect a decrease in OPN expression after GANT61 treatment in any cell line (data not shown). This evidence concerns the gene GLI1 and melanoma.